Despite significant progress over the last few decades, meningitis remains a much-feared disease worldwide with a high case fatality rate and a propensity to cause epidemics that present a major challenge for health systems, economies and society. Meningitis caused an estimated 250 000 deaths in 2019, leaving one in five affected individuals with long-term devastating sequelae, and has serious consequences with considerable emotional, social and financial impact on individuals, families and communities. Meningitis is a largely preventable disease through vaccination, but progress in the fight against the disease is behind other diseases preventable by vaccination.
WHO, with global partners and experts involved in meningitis prevention and control, led the development of a global road map that sets forth a vision and roadmap to defeat meningitis by 2030, involving hundreds of experts, Member States representatives, partners, Civil Society Organization as well as private sector representatives, through multidisciplinary, iterative and comprehensive consultations.
The Defeating meningitis by 2030 global road map has been approved by the Seventy-third session of the World Health Assembly in November 2020 (resolution WHA73.9).
The road map sets a comprehensive vision for 2030 “Towards a world free of meningitis”, with three visionary goals:
It sets a path to achieve goals, through concerted actions across five interconnected pillars:
While the road map on defeating meningitis addresses all meningitis regardless of the cause, it primarily focuses on the main causes of acute bacterial meningitis (meningococcus, pneumococcus, Haemophilus influenzae and group B streptococcus), that were responsible for over 50% of the 250 000 deaths from all-cause meningitis in 2019, cause other invasive disease such as sepsis and pneumonia, and against which effective vaccines are available (or will be in a near future).
Defeating meningitis by 2030 global road map - Highlights from WHO launch event, 28 September 2021
Defeating meningitis by 2030: a global road map
Governance
Background on the process
Technical Taskforce Meeting
Implementation
News
All →Publications
Group B streptococcus (GBS) is an important cause of disease burden in every region worldwide, contributing to neonatal/ infant infection, deaths, disability,...
This report describes the potential financial outcomes that can be expected from successful development of a GBS vaccine that can attain global registration....
Group B streptococcus (GBS) is an important cause of disease burden in every region worldwide, contributing to neonatal/ infant infection, deaths, disability,...
Maternal immunization can play an important role in improving maternal, fetal and neonatal health and has the potential to be an important tool in the...
External publications
Brian Greenwood, Samba Sow, Marie-Pierre Preziosi. August 2021.
James M. Stuart, University of Bristol, Bristol, UK. September 2021
Health topic
Fact sheet
Social media assets
Click on images to download